Abnova Taiwan logo

4133 - Abnova Taiwan Share Price

TWD48.35 1.0  2.0%

Last Trade - 07/05/21

Small Cap
Market Cap £75.4m
Enterprise Value £69.0m
Revenue £12.1m
Position in Universe 3732nd / 6094
Unlock 4133 Revenue
Relative Strength (%)
1m -10.9%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -70.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
451.4 439.8 475.1 426 414.2 456.4 +0.2%
-30.9 +20.6 +8.3 -20.1 -92.9 +1,021
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2021, Abnova(Taiwan) Corporation. revenues increased 14% to NT$114.3M.Net income increased 27% to NT$9.8M. Revenues reflectAmerica segment increase of 26% to NT$61.6M, Other ForeignCountries segment increase of 12% to NT$23.7M. Net incomebenefited from Expected Credit Gain/Loss decrease of 65% toNT$743K (expense), Selling Expense decrease of 4% toNT$10.2M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for 4133
Graphical History


4133 Revenue Unlock 4133 Revenue

Net Income

4133 Net Income Unlock 4133 Revenue

Normalised EPS

4133 Normalised EPS Unlock 4133 Revenue

PE Ratio Range

4133 PE Ratio Range Unlock 4133 Revenue

Dividend Yield Range

4133 Dividend Yield Range Unlock 4133 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
4133 EPS Forecasts Unlock 4133 Revenue
Profile Summary

ABNOVA (TAIWAN) CORPORATION is a Taiwan-based company principally engaged in the manufacturing and sales of antibodies and proteins. The Company's products mainly include monoclonal antibodies, polyclonal antibodies, protein fragments, full-length proteins, active proteins, antibody pairs, fluorescence in situ hybridization probe and others. The Company's monoclonal and polyclonal antibodies are primarily applied in medical testing reagents, agricultural testing, industrial purification, medical treatment and other fields. Its proteins are mainly applied in medical testing reagents, agricultural testing, medical treatment, protein engineering and other fields. Its products are mainly traded in Taiwan, Americas and Europe.

Last Annual December 31st, 2020
Last Interim March 31st, 2021
Incorporated January 4, 2002
Public Since May 27, 2008
No. of Shareholders: n/a
No. of Employees: 190
Sector Healthcare
Industry Biotechnology & Medical Research
Index Taiwan SE Weighted ,
Exchange Taiwan Stock Exchange
Shares in Issue 60,554,000
Free Float (0.0%)
Eligible for
4133 Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for 4133
Upcoming Events for 4133
Frequently Asked Questions for Abnova Taiwan
What is the Abnova Taiwan share price?

As of 07/05/21, shares in Abnova Taiwan are trading at TWD48.35, giving the company a market capitalisation of £75.4m. This share price information is delayed by 15 minutes.

How has the Abnova Taiwan share price performed this year?

Shares in Abnova Taiwan are currently trading at TWD48.35 and the price has moved by -6.12% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Abnova Taiwan price has moved by -40.61% over the past year.

What are the analyst and broker recommendations for Abnova Taiwan?

Of the analysts with advisory recommendations for Abnova Taiwan, there are there are currently 0 "buy" , 1 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Abnova Taiwan is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Abnova Taiwan next release its financial results?

Abnova Taiwan is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2022-03-31
What is the Abnova Taiwan dividend yield?

The Abnova Taiwan dividend yield is 1.24% based on the trailing twelve month period.

Does Abnova Taiwan pay a dividend?

Last year, Abnova Taiwan paid a total dividend of 0.6, and it currently has a trailing dividend yield of 1.24%. Looking ahead, Abnova Taiwan has not announced an ex-dividend date yet.

When does Abnova Taiwan next pay dividends?

Abnova Taiwan has yet to annouce their ex-dividend date. The historic dividend yield on Abnova Taiwan shares is currently 1.24%.

How do I buy Abnova Taiwan shares?

To buy shares in Abnova Taiwan you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Abnova Taiwan?

Shares in Abnova Taiwan are currently trading at TWD48.35, giving the company a market capitalisation of £75.4m.

Where are Abnova Taiwan shares listed? Where are Abnova Taiwan shares listed?

Here are the trading details for Abnova Taiwan:

Country of listing: Taiwan
Exchange: TAI
Ticker Symbol: 4133
What kind of share is Abnova Taiwan?

Based on an overall assessment of its quality, value and momentum, Abnova Taiwan is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Abnova Taiwan share price forecast 2021?

We were not able to load any forecast data for Abnova Taiwan.

How can I tell whether the Abnova Taiwan share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Abnova Taiwan. Over the past six months, the relative strength of its shares against the market has been -39.25%. At the current price of TWD48.35, shares in Abnova Taiwan are trading at -24.56% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Abnova Taiwan PE Ratio?

The Abnova Taiwan PE ratio based on its reported earnings over the past 12 months is 76.04. The shares are currently trading at TWD48.35.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Abnova Taiwan?

Abnova Taiwan's management team is headed by:

Wilber Huang - CHM
Qijing Qiu - DRC
Hanwen Guan - DGM
Yaping Zhang - OTH
Yuehong Chen - DRC
Fangwen Li - DRC
Jiaxun Lin - IND
Jinjun Su - IND
Who are the major shareholders of Abnova Taiwan?

Here are the top five shareholders of Abnova Taiwan based on the size of their shareholding:

Huang (Wilber) Individual Investor
Percentage owned: 6.03% (3.65m shares)
Kun Mu Investment Co., Ltd. Corporation
Percentage owned: 4.04% (2.45m shares)
Buo Hong Investment Co., Ltd. Corporation
Percentage owned: 3.04% (1.84m shares)
Chen (Hao Yuan-a) Individual Investor
Percentage owned: 2.99% (1.81m shares)
Su (Shengyi) Individual Investor
Percentage owned: 1.87% (1.13m shares)
Similar to 4133
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.